Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection
Copyright © 2020 Elsevier España, S.L.U. y SEMICYUC. All rights reserved..
Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.
| Errataetall: |
CommentIn: Med Intensiva (Engl Ed). 2021 Jun-Jul;45(5):320-321. - PMID 32507317 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Medicina intensiva - 44(2020), 7 vom: 15. Okt., Seite 429-438 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2 |
|---|
| Beteiligte Personen: |
Cinesi Gómez, César [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 23.10.2020 Date Revised 18.11.2021 published: Print-Electronic CommentIn: Med Intensiva (Engl Ed). 2021 Jun-Jul;45(5):320-321. - PMID 32507317 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.medin.2020.03.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308970845 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308970845 | ||
| 003 | DE-627 | ||
| 005 | 20231225132902.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.medin.2020.03.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1029.xml |
| 035 | |a (DE-627)NLM308970845 | ||
| 035 | |a (NLM)32312600 | ||
| 035 | |a (PII)S0210-5691(20)30094-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cinesi Gómez, César |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection |
| 246 | 3 | 3 | |a Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2020 | ||
| 500 | |a Date Revised 18.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Med Intensiva (Engl Ed). 2021 Jun-Jul;45(5):320-321. - PMID 32507317 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier España, S.L.U. y SEMICYUC. All rights reserved. | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials | ||
| 650 | 4 | |a Consensus Development Conference | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Aerosol-generating procedures | |
| 650 | 4 | |a Control de infección | |
| 650 | 4 | |a High-flow nasal therapy | |
| 650 | 4 | |a Infection control | |
| 650 | 4 | |a Non-invasive mechanical ventilation | |
| 650 | 4 | |a Procedimientos generadores de aerosoles | |
| 650 | 4 | |a Terapia nasal de alto flujo | |
| 650 | 4 | |a Ventilación mecánica no invasiva | |
| 650 | 7 | |a Aerosols |2 NLM | |
| 700 | 1 | |a Peñuelas Rodríguez, Óscar |e verfasserin |4 aut | |
| 700 | 1 | |a Luján Torné, Manel |e verfasserin |4 aut | |
| 700 | 1 | |a Egea Santaolalla, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Masa Jiménez, Juan Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a García Fernández, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Carratalá Perales, José Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Heili-Frades, Sarah Béatrice |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrer Monreal, Miquel |e verfasserin |4 aut | |
| 700 | 1 | |a de Andrés Nilsson, José M |e verfasserin |4 aut | |
| 700 | 1 | |a Lista Arias, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez Rocamora, Juan Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Garrote, José Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Zamorano Serrano, Miguel J |e verfasserin |4 aut | |
| 700 | 1 | |a González Martínez, Mónica |e verfasserin |4 aut | |
| 700 | 1 | |a Farrero Muñoz, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Mediano San Andrés, Olga |e verfasserin |4 aut | |
| 700 | 1 | |a Rialp Cervera, Gemma |e verfasserin |4 aut | |
| 700 | 1 | |a Mas Serra, Arantxa |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández Martínez, Gonzalo |e verfasserin |4 aut | |
| 700 | 1 | |a de Haro López, Candelaria |e verfasserin |4 aut | |
| 700 | 1 | |a Roca Gas, Oriol |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrer Roca, Ricard |e verfasserin |4 aut | |
| 700 | 1 | |a Romero Berrocal, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrando Ortola, Carlos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicina intensiva |d 2017 |g 44(2020), 7 vom: 15. Okt., Seite 429-438 |w (DE-627)NLM25948640X |x 2173-5727 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2020 |g number:7 |g day:15 |g month:10 |g pages:429-438 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medin.2020.03.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2020 |e 7 |b 15 |c 10 |h 429-438 | ||